Falcon served as strategic advisor to Teijin Pharma, a manufacturer of pharmaceutical and home healthcare products created to prevent bone and joint, respiratory, and cardiovascular and metabolic diseases.  Falcon performed buy-side advisory services during its acquisition of Pacific Pulmonary Services.